EZH2 Inhibition to Counteract Oral Cancer Progression through Wnt/β-Catenin Pathway Modulation.
Campolo M, Scuderi SA, Filippone A, Bova V, Lombardo SP, Colarossi L, Sava S, Capra AP, De Gaetano F, Portelli M, Militi A, Esposito E, Paterniti I.
Campolo M, et al.
Pharmaceuticals (Basel). 2024 Aug 22;17(8):1102. doi: 10.3390/ph17081102.
Pharmaceuticals (Basel). 2024.
PMID: 39204206
Free PMC article.